Lars Edvinsson
Department of Internal Medicine
Lund University Hospital
S-221 85 Lund
Sweden. Electronic address:
Name/email consistency: high
- Basic mechanisms of migraine and its acute treatment. Edvinsson, L., Villalón, C.M., Maassenvandenbrink, A. Pharmacol. Ther. (2012)
- Effect of the calcitonin gene-related peptide (CGRP) receptor antagonist telcagepant in human cranial arteries. Edvinsson, L., Chan, K.Y., Eftekhari, S., Nilsson, E., de Vries, R., Säveland, H., Dirven, C.M., Danser, A.H., MaassenVanDenBrink, A. Cephalalgia (2010)
- New drugs in migraine treatment and prophylaxis: telcagepant and topiramate. Edvinsson, L., Linde, M. Lancet (2010)
- CGRP receptor antagonism and migraine. Edvinsson, L., Ho, T.W. Neurotherapeutics (2010)
- Cerebral ischemia induces microvascular pro-inflammatory cytokine expression via the MEK/ERK pathway. Maddahi, A., Edvinsson, L. J. Neuroinflammation (2010)
- Cerebrovascular endothelin receptor upregulation in cerebral ischemia. Edvinsson, L. Curr. Vasc. Pharmacol (2009)
- CGRP blockers in migraine therapy: where do they act? Edvinsson, L. Br. J. Pharmacol. (2008)
- Comparison of CGRP and NO responses in the human peripheral microcirculation of migraine and control subjects. Edvinsson, M.L., Edvinsson, L. Cephalalgia (2008)
- Cerebrovascular angiotensin AT1 receptor regulation in cerebral ischemia. Edvinsson, L. Trends Cardiovasc. Med. (2008)
- The blood-brain barrier in migraine treatment. Edvinsson, L., Tfelt-Hansen, P. Cephalalgia (2008)
- CGRP-receptor antagonism in migraine treatment. Edvinsson, L. Lancet (2008)
- Inhibitory effect of BIBN4096BS, CGRP(8-37), a CGRP antibody and an RNA-Spiegelmer on CGRP induced vasodilatation in the perfused and non-perfused rat middle cerebral artery. Edvinsson, L., Nilsson, E., Jansen-Olesen, I. Br. J. Pharmacol. (2007)
- Novel migraine therapy with calcitonin gene-regulated peptide receptor antagonists. Edvinsson, L. Expert Opin. Ther. Targets (2007)
- CGRP-receptor antagonism in migraine treatment. Edvinsson, L., Petersen, K.A. CNS. Neurol. Disord. Drug. Targets (2007)
- Neuropeptide Y and the cerebral circulation. Edvinsson, L. EXS (2006)
- Triptan-induced contractile (5-HT1B receptor) responses in human cerebral and coronary arteries: relationship to clinical effect. Edvinsson, L., Uddman, E., Wackenfors, A., Davenport, A., Longmore, J., Malmsjö, M. Clin. Sci. (2005)
- Clinical data on the CGRP antagonist BIBN4096BS for treatment of migraine attacks. Edvinsson, L. CNS. Drug. Rev (2005)
- Blockade of CGRP receptors in the intracranial vasculature: a new target in the treatment of headache. Edvinsson, L. Cephalalgia (2004)
- New therapeutic target in primary headaches - blocking theCGRP receptor. Edvinsson, L. Expert Opin. Ther. Targets (2003)
- Vasogen's immune modulation therapy (IMT) improves postischemic foot skin blood flow and transcutaneous pO(2) recovery rates in patients with advanced peripheral arterial occlusive disease. Edvinsson, L.I., Edvinsson, M.L., Angus Deveber, G. Int. Angiol (2003)
- Effect of the CGRP receptor antagonist BIBN4096BS in human cerebral, coronary and omental arteries and in SK-N-MC cells. Edvinsson, L., Alm, R., Shaw, D., Rutledge, R.Z., Koblan, K.S., Longmore, J., Kane, S.A. Eur. J. Pharmacol. (2002)
- Calcitonin gene-related peptide (CGRP) in cerebrovascular disease. Edvinsson, L. ScientificWorldJournal (2002)
- Characterisation of the effects of a non-peptide CGRP receptor antagonist in SK-N-MC cells and isolated human cerebral arteries. Edvinsson, L., Sams, A., Jansen-Olesen, I., Tajti, J., Kane, S.A., Rutledge, R.Z., Koblan, K.S., Hill, R.G., Longmore, J. Eur. J. Pharmacol. (2001)
- Pathophysiology of primary headaches. Edvinsson, L. Curr. Pain. Headache. Rep (2001)
- Origin and Co-localization of nitric oxide synthase, CGRP, PACAP, and VIP in the cerebral circulation of the rat. Edvinsson, L., Elsås, T., Suzuki, N., Shimizu, T., Lee, T.J. Microsc. Res. Tech. (2001)
- 5-HT(1B) and 5-HT(1D) receptors in the human trigeminal ganglion: co-localization with calcitonin gene-related peptide, substance P and nitric oxide synthase. Hou, M., Kanje, M., Longmore, J., Tajti, J., Uddman, R., Edvinsson, L. Brain Res. (2001)
- Aspects on the pathophysiology of migraine and cluster headache. Edvinsson, L. Pharmacol. Toxicol. (2001)
- Sensory nerves in man and their role in primary headaches. Edvinsson, L. Cephalalgia (2001)
- Calcitonin gene-related peptide (CGRP) and the pathophysiology of headache: therapeutic implications. Edvinsson, L. CNS. Drugs (2001)
- Amylin: localization, effects on cerebral arteries and on local cerebral blood flow in the cat. Edvinsson, L., Goadsby, P.J., Uddman, R. ScientificWorldJournal (2001)
- Calcitonin gene-related peptide and nitric oxide in the trigeminal ganglion: cerebral vasodilatation from trigeminal nerve stimulation involves mainly calcitonin gene-related peptide. Edvinsson, L., Mulder, H., Goadsby, P.J., Uddman, R. J. Auton. Nerv. Syst. (1998)
- Innervation of the human middle meningeal artery: immunohistochemistry, ultrastructure, and role of endothelium for vasomotility. Edvinsson, L., Gulbenkian, S., Barroso, C.P., Cunha e Sá, M., Polak, J.M., Mortensen, A., Jørgensen, L., Jansen-Olesen, I. Peptides (1998)
- Molecular aspects of headaches and migraines. 7th International Headache Research Seminar. Copenhagen, Denmark, 22-24 November 1996. Edvinsson, L., Olesen, J. Mol. Med. Today (1997)
- Expression of calcitonin gene-related peptide1 receptor mRNA in human trigeminal ganglia and cerebral arteries. Edvinsson, L., Cantera, L., Jansen-Olesen, I., Uddman, R. Neurosci. Lett. (1997)
